missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD57 Antibody (HNK-1 or Leu-7) - Azide and BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NBP2-47787-0.1MG
This item is not returnable.
View return policy
Description
CD57 Monoclonal specifically detects CD57 in Human, Rat (Negative) samples. It is validated for Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Immunofluorescence.
Specifications
| beta-1,3-Glucuronyltransferase 1/B3GAT1 | |
| Monoclonal | |
| 1.0 mg/mL | |
| Immunohistochemistry-Paraffin : 2 - 4 ug/ml, Immunofluorescence : 0.5 - 1.0 ug/ml | |
| Beta-1,3-glucuronyltransferase 1, beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P), EC 2.4.1.135, galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1, GlcAT-P, GLCATPGLCUATP, glcUAT-P, Glucuronosyltransferase P, NK1, NK-1, UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase | |
| Mouse | |
| Protein A or G purified | |
| RUO | |
| Primary | |
| Anti-CD57 marks a subset of lymphocytes known as natural killer (NK) cells. Follicular center cell lymphomas often contain many NK cells within the neoplastic follicles. Anti-CD57 also stains neuroendocrine cells and their derived tumors, including carcinoid tumor and medulloblastoma. Anti-CD57 can also be useful in separating type B3 thymoma from thymic carcinoma when combined with a panel that includes antibodies against GLUT1, CD5, and CEA. | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
| IgM κ |
| Immunohistochemistry (Paraffin), Immunofluorescence | |
| HNK-1 or Leu-7 | |
| Unconjugated | |
| PBS with No Preservative | |
| B3GAT1 | |
| Human peripheral blood mononuclear cells | |
| 0.1 mg | |
| Cancer, Immunology | |
| 27087 | |
| Human, Rat (Negative) | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction